U S PHYSICAL THERAPY INC /NV (USPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 300M 600M 900M Q3 '21: 482.7M Q4 '21: 495M Q1 '22: 514.4M Q2 '22: 528.1M Q3 '22: 541.8M Q4 '22: 553.1M Q1 '23: 569.9M Q2 '23: 580.8M Q3 '23: 591.2M Q4 '23: 604.8M Q1 '24: 612M Q2 '24: 627.7M Q3 '24: 645.7M Q4 '24: 671.3M Q1 '25: 699.5M Q2 '25: 729.6M Q3 '25: 758.7M Q4 '25: 781M Q1 '26: 795.5M Q2 '26: 812.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 60M 120M 180M Q3 '21: 119.1M Q4 '21: 117.2M Q1 '22: 117.9M Q2 '22: 114.4M Q3 '22: 111.4M Q4 '22: 112M Q1 '23: 116.3M Q2 '23: 117.7M Q3 '23: 118.8M Q4 '23: 121.5M Q1 '24: 119.1M Q2 '24: 120.7M Q3 '24: 121.9M Q4 '24: 123.9M Q1 '25: 126.6M Q2 '25: 134.3M Q3 '25: 142.1M Q4 '25: 149.7M Q1 '26: 151.4M Q2 '26: 151.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

0 35M 70M 105M Q3 '21: 72.4M Q4 '21: 70.6M Q1 '22: 70.7M Q2 '22: 68.5M Q3 '22: 66.5M Q4 '22: 56.8M Q1 '23: 58.8M Q2 '23: 58.7M Q3 '23: 59.7M Q4 '23: 50.5M Q1 '24: 48.4M Q2 '24: 43.9M Q3 '24: 40.9M Q4 '24: 63M Q1 '25: 67.7M Q2 '25: 77.1M Q3 '25: 89.6M Q4 '25: 86.7M Q1 '26: 79.5M Q2 '26: 76.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

0 20M 40M 60M Q3 '21: 43.6M Q4 '21: 40.8M Q1 '22: 41.5M Q2 '22: 40.2M Q3 '22: 39.8M Q4 '22: 32.2M Q1 '23: 30.8M Q2 '23: 30.5M Q3 '23: 30.2M Q4 '23: 28.2M Q1 '24: 28.9M Q2 '24: 25.5M Q3 '24: 22.8M Q4 '24: 31.4M Q1 '25: 33.3M Q2 '25: 38.2M Q3 '25: 44.7M Q4 '25: 39.6M Q1 '26: 34.7M Q2 '26: 32.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 250M 500M 750M Q3 '21: 363.5M Q4 '21: 377.8M Q1 '22: 396.5M Q2 '22: 413.7M Q3 '22: 430.4M Q4 '22: 441.1M Q1 '23: 453.7M Q2 '23: 463.1M Q3 '23: 472.4M Q4 '23: 483.3M Q1 '24: 492.9M Q2 '24: 507M Q3 '24: 523.8M Q4 '24: 547.4M Q1 '25: 572.9M Q2 '25: 595.3M Q3 '25: 616.6M Q4 '25: 631.3M Q1 '26: 644.1M Q2 '26: 660.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 30M 60M 90M Q3 '21: 85.9M Q4 '21: 76.4M Q1 '22: 70.4M Q2 '22: 68.4M Q3 '22: 57.1M Q4 '22: 58.5M Q1 '23: 58.2M Q2 '23: 69.8M Q3 '23: 72.4M Q4 '23: 82M Q1 '24: 75M Q2 '24: 76.6M Q3 '24: 82.4M Q4 '24: 74.9M Q1 '25: 65.8M Q2 '25: 71.7M Q3 '25: 69.5M Q4 '25: 75.1M Q1 '26: 83.5M Q2 '26: 83M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 30M 60M 90M Q3 '21: 77.8M Q4 '21: 68.2M Q1 '22: 61.3M Q2 '22: 58.9M Q3 '22: 47.6M Q4 '22: 50.3M Q1 '23: 50.5M Q2 '23: 61.6M Q3 '23: 64.4M Q4 '23: 72.7M Q1 '24: 66M Q2 '24: 67.7M Q3 '24: 73.4M Q4 '24: 65.8M Q1 '25: 55.9M Q2 '25: 60.9M Q3 '25: 56.9M Q4 '25: 61M Q1 '26: 66.7M Q2 '26: 64.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6M 12M 18M Q1 '20: 12.8M Q2 '20: 12.8M Q3 '20: 12.8M Q1 '21: 12.9M Q2 '21: 12.9M Q3 '21: 12.9M Q1 '22: 12.9M Q2 '22: 13M Q3 '22: 13M Q1 '23: 13M Q2 '23: 13.7M Q3 '23: 15M Q1 '24: 15M Q2 '24: 15.1M Q3 '24: 15.1M Q1 '25: 15.1M Q2 '25: 15.2M Q3 '25: 15.2M Q1 '26: 15.2M Q2 '26: 15.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q4 '18: 1.31 Q1 '19: 1.43 Q2 '19: 1.80 Q3 '19: 2.33 Q4 '19: 2.45 Q1 '20: 2.26 Q2 '20: 2.40 Q3 '20: 2.35 Q4 '20: 2.48 Q1 '22: 2.87 Q2 '22: 2.92 Q3 '22: 2.98 Q4 '22: 2.24 Q1 '23: 2.15 Q2 '23: 1.92 Q3 '23: 1.71 Q4 '24: 1.84 Q1 '25: 2.18 Q2 '25: 2.29 Q3 '25: 2.38 Q1 '19 Q4 '19 Q3 '20 Q2 '22 Q1 '23 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.